INS and obesity disorder: However, differences between the effects of rosiglitazone and pioglitazone became apparent under the conditions of the combination treatment, especially with respect to the unique anti-obesity effect of the treatment using rosiglitazone, and relatively strong insulin-sensitizing and hypolipidaemic effects of the pioglitazone-based treatments.